Kailos Genetics' Series A Round

Kailos Genetics raised a round of funding on December 20, 2011.

Kailos Genetics helps predict individual patient response to drugs, enabling healthcare providers to identify responders and non-responders to potential drug therapy, avoid adverse drug reactions, and…

Articles about Kailos Genetics' Series A Round: